| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.016 | 0.9 |